What is PUCAI?

The Pediatric Ulcerative Colitis Activity Index (PUCAI) is a clinician- and caregiver-facing instrument used to quantify symptomatic disease activity in children with ulcerative colitis (UC). It aggregates six domains that reflect abdominal discomfort, bleeding, stool form and frequency, disruption of sleep, and functional impact on daily activity. Each domain contributes weighted points; the items are summed into a single total. The index is designed to be practical at the bedside or in outpatient visits because it does not require endoscopy, imaging, or laboratory values to produce a score.

PUCAI is widely used in pediatric IBD care for serial monitoring, communication among providers and families, and as an anchor for research definitions of response and remission when protocol criteria specify a symptom-based threshold. Like any clinical score, it captures visible and reported illness burden; it does not by itself confirm mucosal inflammation, infection, or complications. Clinical decisions should integrate history, examination, growth and nutrition, medications, objective inflammation when available, and specialist judgment.

When is it used?

PUCAI applies to pediatric patients with a diagnosis of ulcerative colitis when you want a structured snapshot of current symptoms. Typical settings include clinic follow-up, telephone or telehealth check-ins, acute flare assessment, and tracking change after therapy adjustments. Because stool frequency and bleeding can shift quickly, repeating the score over days to weeks often adds more information than a single isolated value.

The six domains and why they matter

Abdominal pain. Pain is scored by how much it intrudes on the child’s day, from absent, to noticeable but ignorable, to pain that cannot be ignored. Higher points reflect greater distress and often parallel colonic inflammation or severe urgency, though non-inflammatory causes of pain still warrant consideration.

Rectal bleeding. This domain carries the largest point ceiling because visible bleeding correlates closely with mucosal ulceration in UC. Categories distinguish absent bleeding from smaller amounts affecting a minority or majority of stools, versus larger-volume bleeding across most stools. More dramatic bleeding receives more points.

Stool consistency (most stools). Formed, partially formed, and completely unformed stool patterns are ranked. Increasing diarrhea burden raises the score and mirrors increased colonic fluid loss and urgency.

Number of stools per 24 hours. Frequency bands step up from low daily stool counts through intermediate ranges to very high stool volumes. More bowel movements usually reflect more active disease but can also reflect irritability after infection or dietary change, so context matters.

Nocturnal stools. Stools that wake the child or occur overnight receive the highest category weight within this binary item. Nocturnal symptoms suggest loss of circadian control of bowel habits and often flag more troubling activity than daytime frequency alone.

Activity level. Functional impairment is captured from no limitation, through occasional restriction of normal activities, to severe limitation. This domain connects inflammatory burden to quality of life and school participation.

How scoring works

For each domain you select the answer that best matches the prior day or the timeframe your team standardizes (many workflows use the last 48 hours or similar). Points from all six rows are added. The theoretical minimum is 0 and the maximum total is 85 when every domain is at its worst scored level.

Total PUCAI = sum of all domain points. Range 0 to 85.

Interpreting the total score

Consensus-oriented summaries typically stratify PUCAI totals into bands that guide intensity of evaluation and escalation discussions. Exact treatment choices remain guideline- and patient-specific.

• Remission: total score less than 10. Often treated as minimal symptomatic activity relative to pediatric UC care pathways.
• Mild activity: 10 through 34.
• Moderate activity: 35 through 64.
• Severe activity: 65 or higher. This range usually prompts urgent specialist involvement; inpatient care and intravenous corticosteroids are common considerations when clinically appropriate. Steroid-refractory severe inflammation may lead to rescue medical therapy or surgical evaluation depending on response and institutional pathways.

In severe hospitalized cohorts, persistent high PUCAI after several days of intravenous steroids has been linked in some studies to higher short-term colectomy risk, which is why early reassessment and coordinated escalation matter. That pattern illustrates how the score supports timing decisions rather than replacing bedside judgment.

Strengths and limits

Strengths: PUCAI is quick, inexpensive, and repeatable. It aligns well with how families experience flares and improves communication about urgency and functional impact. It is familiar to pediatric gastroenterology teams across regions.

Limits: Symptoms may lag or diverge from mucosal healing; a child can feel better while inflammation persists, or may report severe symptoms during infection or irritable bowel–like overlay. Rectal bleeding scales can be frightening to caregivers; clear counseling helps. Always weigh adherence, concurrent medications, infections including C. difficile, and extraintestinal manifestations alongside the numeric score.

Practical pearls

• Use a consistent recall window for stool counts and bleeding when comparing visits.
• Track trends: a rising score after therapy changes may signal inadequate control or adherence barriers.
• Pair PUCAI with objective markers when treatment decisions depend on inflammation control, not symptoms alone.
• Involve caregivers and, when age-appropriate, the child in choosing answers so the score reflects lived experience.